Ignite Creation Date:
2024-05-06 @ 7:49 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02603809
Status:
COMPLETED
Last Update Posted:
2022-11-23
First Post:
2015-11-09
Brief Title:
Dose-finding Study With ACT-132577 Aprocitentan in Participants With Essential Hypertension
Sponsor:
Idorsia Pharmaceuticals Ltd
Organization:
Idorsia Pharmaceuticals Ltd
Organization Data
Organization:
Idorsia Pharmaceuticals Ltd
Class:
INDUSTRY
Study ID:
AC-080A201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Idorsia Pharmaceuticals Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None